Antiphospholipid Antibodies, Portal and Mesenteric Thrombosis and Carcinoid Tumor: A Case Report

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 2001; 86(05): 1334
DOI: 10.1055/s-0037-1616071

Letters to the Editor

Schattauer GmbH

Authors

A. Aranguren

¹Hematology Service, University Clinic of Navarra, Pamplona, Spain
M. Pérez-Salazar

¹Hematology Service, University Clinic of Navarra, Pamplona, Spain
J. A. Páramo

¹Hematology Service, University Clinic of Navarra, Pamplona, Spain
J. Zozaya

²Digestive Service, Hospital of Navarra, Pamplona, Spain
E. Rocha

¹Hematology Service, University Clinic of Navarra, Pamplona, Spain

Received 27 March 2001

Accepted after resubmission 31 July 2001

Publication Date:
13 December 2017 (online)

References
1 Sorensen HT, Mellemkjaer L, Steffensen HF, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.

Reference Link Ris
Crossref PubMed Search in Google Scholar
2 Baron JA, Gridley G, Weiderpass E, Nyrén O, Linet M. Venous thromboembolism and cancer. Lancet 1998; 351: 1077-80.

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Bax NDS, Woods HF, Batchelor A, Jennings M. Clinical Manifestations of Carcinoid Disease. World J Surg 1996; 20: 142-6.

Reference Link Ris
Crossref PubMed Search in Google Scholar
4 Anderson AS, Krauss D, Lang R. Cardiovascular complications of malignant carcinoid disease. Am Heart J 1997; 134: 693-702.

Reference Link Ris
Crossref PubMed Search in Google Scholar
5 Miura K. Primary carcinoid tumour of the liver. Am J Clin Path 1988; 89: 561-4.

Reference Link Ris
Crossref PubMed Search in Google Scholar